The Therapeutic Regimen For Patients With Mcc

3656 Words Oct 27th, 2016 15 Pages
The disproportionately high health care utilization and resulting colossal Medicare spending among a small fraction of Medicare beneficiaries is well established.56,70,71 Nearly 50% of the health care spending is incurred by 5% of the Medicare population.58 These high-cost health care users are commonly referred to as “super-utilizers”.71 They often have complex health and social issues and have high rates of multiple chronic conditions (MCC) including mental health disorders.56,58 Substantial research shows that patients with MCC and polypharmacy are at high risk of medication nonadherence. The therapeutic regimen for patients with MCC is complex, often involving multiple concurrent medications, which puts them at greater risk of drug-drug interactions and makes these patients less likely to be adherent to their therapy.72-74 In addition, patients who experience frequent transitions of care are particularly at higher risk of drug therapy problems and medication discrepancies, which may contribute to low medication adherence. For instance, after hospital discharge nearly 14% to 75% of patients experience medication discrepancies,13,17,18,75 11% experience adverse drug events (ADE),20 and 23% to 48% do not take their medications as directed.14,18 Medication management is critical for super-utilizing patients since nonadherence to medications is associated with poor health outcomes, and higher hospital admissions and costs.5,38

The World Health Organization has reported that…
Open Document